Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Yi Chu

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|March 14, 2022
Development and characterization of anti-galectin-9 antibodies that protect T cells from galectin-9-induced cell deathRiyao Yang, Linlin Sun, Ching-Fei Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2016
Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-resistance with Paclitaxel in the Urothelial Carcinoma of the Urinary BladderWei-Jan Wang, Chien-Feng Li, Yu-Yi Chu, et al.
Cancer Cell International|February 24, 2026
CCAAT/enhancer-binding protein delta regulates miRs-4257 and 3156 to attenuate the interleukin 12 through small extracellular vesicle transmission in glioblastomaYu-Yi Chu, Chiung-Yuan Ko, Shao-Ming Wang, et al.
Plos One|October 1, 2014
CD4⁺ T cells expressing latency-associated peptide and Foxp3 are an activated subgroup of regulatory T cells enriched in patients with colorectal cancerJayashri Mahalingam, Chun-Yen Lin, Jy-Ming Chiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2012
LAP+CD4+ T cells are suppressors accumulated in the tumor sites and associated with the progression of colorectal cancerJayashri Mahalingam, Yung-Chang Lin, Jy-Ming Chiang, et al.
Cancer Research|December 22, 2018
EGFR and c-MET Cooperate to Enhance Resistance to PARP Inhibitors in Hepatocellular CarcinomaQiongzhu Dong, Yi Du, Hui Li, et al.
Cell Death & Disease|November 10, 2017
Bortezomib-induced miRNAs direct epigenetic silencing of locus genes and trigger apoptosis in leukemiaYu-Yi Chu, Chiung-Yuan Ko, Shao-Ming Wang, et al.
International Journal of Cancer|August 22, 2012
Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancerYung-Chang Lin, Jayashri Mahalingam, Jy-Ming Chiang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2012
The indispensable role of CCR5 for in vivo suppressor function of tumor-derived CD103+ effector/memory regulatory T cellsLi-Yuan Chang, Yung-Chang Lin, Chiao-Wen Kang, et al.
Scientific Reports|October 24, 2015
Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancerChiao-Wen Kang, Avijit Dutta, Li-Yuan Chang, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|March 14, 2022
Development and characterization of anti-galectin-9 antibodies that protect T cells from galectin-9-induced cell deathRiyao Yang, Linlin Sun, Ching-Fei Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2016
Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-resistance with Paclitaxel in the Urothelial Carcinoma of the Urinary BladderWei-Jan Wang, Chien-Feng Li, Yu-Yi Chu, et al.
Cancer Cell International|February 24, 2026
CCAAT/enhancer-binding protein delta regulates miRs-4257 and 3156 to attenuate the interleukin 12 through small extracellular vesicle transmission in glioblastomaYu-Yi Chu, Chiung-Yuan Ko, Shao-Ming Wang, et al.
Plos One|October 1, 2014
CD4⁺ T cells expressing latency-associated peptide and Foxp3 are an activated subgroup of regulatory T cells enriched in patients with colorectal cancerJayashri Mahalingam, Chun-Yen Lin, Jy-Ming Chiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2012
LAP+CD4+ T cells are suppressors accumulated in the tumor sites and associated with the progression of colorectal cancerJayashri Mahalingam, Yung-Chang Lin, Jy-Ming Chiang, et al.
Cancer Research|December 22, 2018
EGFR and c-MET Cooperate to Enhance Resistance to PARP Inhibitors in Hepatocellular CarcinomaQiongzhu Dong, Yi Du, Hui Li, et al.
Cell Death & Disease|November 10, 2017
Bortezomib-induced miRNAs direct epigenetic silencing of locus genes and trigger apoptosis in leukemiaYu-Yi Chu, Chiung-Yuan Ko, Shao-Ming Wang, et al.
International Journal of Cancer|August 22, 2012
Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancerYung-Chang Lin, Jayashri Mahalingam, Jy-Ming Chiang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2012
The indispensable role of CCR5 for in vivo suppressor function of tumor-derived CD103+ effector/memory regulatory T cellsLi-Yuan Chang, Yung-Chang Lin, Chiao-Wen Kang, et al.
Scientific Reports|October 24, 2015
Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancerChiao-Wen Kang, Avijit Dutta, Li-Yuan Chang, et al.
Pageof 4